Resources
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 19 December 2022
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 2nd meeting on 19 December 2022.
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 1 December 2022
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 1st meeting on 1 December 2022.
Health Technology Assessment Policy and Methods Review Reference Committee Communique – 27 January 2023 meeting
An update from the Health Technology Assessment Policy and Methods Review Reference Committee following its meeting on 27 January 2023.
Cracks in the ice app
The Cracks in the ice app provides trusted, evidence-based, and up-to-date information and resources about crystal methamphetamine (ice) for the Australian community.
Budget 2022–23: Addressing the impact of alcohol and other drugs
A Budget 2022–23 fact sheet.
Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021.
ANACAD summary of activities 2020–21
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2020 to 30 June 2021.
ANACAD summary of activities 2019–20
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2019 to 30 June 2020.
Evaluation of the National Ice Action Strategy (NIAS)
This document is a response to the findings of the National Ice taskforce in 2015. This report provides a comprehensive assessment of the NIAS.
Opioid Prescribing Practices Project - Key Outcomes
This report outlines the findings of a randomised controlled trial (RCT) conducted by the Department of Health. The RCT explored whether a letter designed with behavioural insights principles would help GPs reflect on their opioid prescribing.
Certification statement – Safe and effective use of prescription opioids campaign
This certificate of compliance, signed by Secretary Brendan Murphy, certifies that the safe and effective prescription opioids campaign complies with relevant guidelines and policies.
Real Time Prescription Monitoring public summary of the Privacy Impact Assessment
The Real Time Prescription Monitoring (RTPM) Privacy Impact Assessment (PIA) was conducted to ensure the Nation Data Exchange (NDE) system contained the appropriate obligations and protections in relation to the collection and storage of individual personal information.
National Drug Strategy 2018 Annual Report
This Annual Report is consistent with the National Drug Strategy 2017–2026.
ANACAD summary of activities 2018–19
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2018 to 30 June 2019.
National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–29
This framework’s aim is that all Australians seeking alcohol and other drug treatment can access high quality treatment appropriate to their needs, when and where they need it. It includes principles for effective treatment, monitoring and evaluation.
MDAF communique – 28 November 2019
A summary of the major items discussed at the fifth MDAF meeting.
National Quality Framework for Drug and Alcohol Treatment Services
This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.
Trends in substance use among Australian secondary school students 1996–2017
This report presents trends data of the Australian Secondary Students' Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs, 1996–2017.
Secondary school students’ use of tobacco, alcohol and other drugs in 2017
This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs.
ANACAD summary of activities 2017–18
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2017 to 30 June 2018.
MDAF communique – 14 June 2018
A summary of the major items discussed at the fourth MDAF meeting.
ANACAD summary of activities 2016–17
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2016 to 30 June 2017.
MDAF communique – 27 November 2017
A summary of the major items discussed at the third MDAF meeting.
National Drug Strategy 2017–2026
A 10-year framework that aims to reduce and prevent the harmful effects of alcohol, tobacco and other drugs.
MDAF communique – 29 May 2017
A summary of the major items discussed at the second MDAF meeting.
Date last updated: